{
    "body": "Is phospholamban phosphorylated by Protein kinase A?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/14577598", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12962492", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15909986", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11502581", 
        "http://www.ncbi.nlm.nih.gov/pubmed/7857766", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19191503", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17548345", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15524173", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10330247", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15049694", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11812163", 
        "http://www.ncbi.nlm.nih.gov/pubmed/3730367", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15362510", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15229104", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16600289", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16226237"
    ], 
    "ideal_answer": [
        "Phospholamban (PLB) is a sarcoplasmic reticulum (SR) protein that is phosphorylated at Ser16 by PKA. Phosphorylation of PLB by PKA reverses the inhibitory action of PLB."
    ], 
    "exact_answer": "yes", 
    "type": "yesno", 
    "id": "54da0c524b1fd0d33c00000b", 
    "snippets": [
        {
            "offsetInBeginSection": 456, 
            "offsetInEndSection": 514, 
            "text": "cAMP-dependent protein kinase (PKA) phosphorylation of PLB", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19191503", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 197, 
            "offsetInEndSection": 246, 
            "text": "phosphorylation of PLN, at either Ser(16) by PKA ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16226237", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 222, 
            "text": "Activation of cardiac muscle sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) by beta1-agonists involves cAMP- and PKA-dependent phosphorylation of phospholamban (PLB), which relieves the inhibitory effects of PLB on SERCA2a. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15909986", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 101, 
            "text": "Phospholamban (PLB) is a sarcoplasmic reticulum (SR) protein that when phosphorylated at Ser16 by PKA", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15524173", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1044, 
            "offsetInEndSection": 1163, 
            "text": "phosphorylation of PLB by the Ca2+-calmodulin-dependent protein kinase (CaMK) and cAMP-dependent protein kinase (PKA). ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15362510", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 897, 
            "offsetInEndSection": 990, 
            "text": "cAMP-dependent protein kinase (PKA)-mediated phospholamban (PLB) phosphorylation at serine-16", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15229104", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 404, 
            "text": "Phospholamban (PLB) is a major target of the beta-adrenergic cascade in the heart, functioning to modulate contractile force by altering the rate of calcium re-sequestration by the Ca-ATPase. Functionally, inhibition by PLB binding is manifested by shifts in the calcium dependence of Ca-ATPase activation toward higher calcium levels; phosphorylation of PLB by PKA reverses the inhibitory action of PLB.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15049694", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 134, 
            "offsetInEndSection": 213, 
            "text": "phosphorylation of both PLB residues (Ser16, PKA site, and Thr17, CaMKII site) ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14577598", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1401, 
            "offsetInEndSection": 1434, 
            "text": "Phosphorylation of Ser(16) by PKA", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12962492", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 2296, 
            "offsetInEndSection": 2370, 
            "text": "stabilization of the structure of PLB following phosphorylation of Ser(16)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12962492", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 173, 
            "text": "Phospholamban (PLB) inhibits the sarcoplasmic reticulum (SR) Ca(2+)-ATPase, and this inhibition is relieved by cAMP-dependent protein kinase (PKA)-mediated phosphorylation. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11502581", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1023, 
            "offsetInEndSection": 1341, 
            "text": "Two-dimensional tryptic peptide maps of phosphorylated phospholamban indicated that cAMP-dependent protein kinase phosphorylates at a single site, A, and Ca2+-calmodulin-dependent protein kinase phosphorylates at sites C1 and C2 in the low molecular weight form, where A is different from C1 but may be the same as C2.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/3957897", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 117, 
            "offsetInEndSection": 455, 
            "text": "Because SR function is regulated by phosphorylation of phospholamban (PLB), a SR protein phosphorylated by cAMP-dependent protein kinase (PKA) at Ser(16)and Ca(2+)-calmodulin-dependent protein kinase (CaMKII) at Thr(17), the phosphorylation of these residues during ischemia and reperfusion was examined in Langendorff-perfused rat hearts", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11812163", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 680, 
            "offsetInEndSection": 908, 
            "text": "These changes were associated with reduced protein expression of sarcoplasmic reticulum Ca(2+)-ATPase (SERCA2a) and protein kinase A phosphorylated phospholamban (PLB), which was reduced in HF, but essentially abolished in VD-HF", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16600289", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1127, 
            "offsetInEndSection": 1499, 
            "text": "The data indicate that 1) phosphorylation of phospholamban at Ser16 by cAMP-dependent protein kinase is the main regulator of beta-adrenergic-induced cardiac relaxation definitely preceding Thr17 phosphorylation and 2) the beta-adrenergic-mediated phosphorylation of Thr17 by Ca2+-calmodulin-dependent protein kinase required influx of Ca2+ through the L-type Ca2+ channel", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10330247", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 407, 
            "offsetInEndSection": 654, 
            "text": "Here we extend this model to explain the reversal of SERCA2a inhibition that occurs after phosphorylation of PLB at Ser(16) by protein kinase A (PKA) and after binding of the anti-PLB monoclonal antibody 2D12, which recognizes residues 7-13 of PLB", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17548345", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 191, 
            "offsetInEndSection": 421, 
            "text": "Phospholamban is phosphorylated in heart by cAMP-dependent protein kinase, cGMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II (CM-kinase-II) and in smooth muscle cells by cGMP-dependent protein kinase", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/7857766", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 268, 
            "text": "Phospholamban, the cardiac sarcoplasmic reticulum proteolipid, is phosphorylated by cAMP-dependent protein kinase, by Ca2+/phospholipid-dependent protein kinase, and by an endogenous Ca2+/calmodulin-dependent protein kinase, the identity of which remains to be defined", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/3730367", 
            "endSection": "abstract"
        }
    ]
}